This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
While the Molecules of the Month are being selected and our deep dive reviews are being prepared, you can find…
Article
2 weeks ago ●
9 mins read
In this update of small molecules in the news for February 2023, we will cover recent: - Molecules in Motion:…
Article
3 weeks ago ●
12 mins read
Our Drug Hunter subscribers at Curie.Bio recently made headlines with the launch of their new >$500M venture fund with a…
Article
3 weeks ago ●
10 mins read
The first, approved non-covalent BTKi, a next generation oral SERD, a bioactive metabolite of a GHSR1a inverse agonist with the…
Article
4 weeks ago ●
1 min read
Mirati’s “Breakthrough” KRASG12C inhibitor, adagrasib, was granted accelerated approval by the FDA in 2022. As it follows Amgen’s first-in-class KRASG12C…
Article
1 month ago ●
12 mins read
Here’s a preview of two molecules acquired in January 2023 among 14 mentioned in this article: deuruxolitinib (CTP-543) This molecule,…
Article
1 month ago ●
2 mins read
Load More
